FULCRUM THERAPEUTICS
3.5950
07-October-24 14:11:27
15 minutes delayed
Stocks
-0.2250
-5.89%
Today's range
3.5700 - 3.7800
ISIN
N/A
Source
NASDAQ
-
Fulcrum Therapeutics Announces Recent Business Highlights and Third Quarter 2022 Financial Results
08 Nov 2022 07:17:58 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Appoints Chief Medical Officer and Chief Scientific Officer
07 Nov 2022 17:00:00 By Nasdaq GlobeNewswire
-
02 Nov 2022 07:05:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® to Participate at Upcoming November Investor Conferences
01 Nov 2022 17:29:02 By Nasdaq GlobeNewswire
-
12 Oct 2022 07:30:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 Oct 2022 17:00:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09 Sep 2022 17:00:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at Upcoming September Investor Conferences
06 Sep 2022 16:01:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® to Participate at the Upcoming Stifel 2022 Biotech Summer Summit
16 Aug 2022 07:05:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Pricing of Public Offering of Common Stock
15 Aug 2022 21:28:02 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
15 Aug 2022 16:08:15 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
11 Aug 2022 07:00:02 By Nasdaq GlobeNewswire
-
04 Aug 2022 08:07:44 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Aug 2022 08:00:02 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 Jul 2022 08:00:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Departure of Chief Medical Officer
11 Jul 2022 17:00:00 By Nasdaq GlobeNewswire
-
05 Jul 2022 07:00:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 Jun 2022 16:02:00 By Nasdaq GlobeNewswire
-
10 Jun 2022 07:02:00 By Nasdaq GlobeNewswire